XML 21 R10.htm IDEA: XBRL DOCUMENT v3.25.1
ACCRUED EXPENSES
3 Months Ended
Mar. 31, 2025
ACCRUED EXPENSES [Abstract]  
ACCRUED EXPENSES

4. ACCRUED EXPENSES

Accrued expenses at March 31, 2025 and December 31, 2024 are as follows:

(dollars in thousands)

    

March 31, 2025

    

December 31, 2024

Accrued expenses

$

396

$

595

Accrued compensation

 

1,038

 

955

Accrued franchise, property and sales and use taxes

195

173

CHC temporary funding assistance

1,011

1,057

Accrued interest

 

19

 

19

$

2,659

$

2,799

The Company uses Change Healthcare (“CHC”), a healthcare technology company owned by UnitedHealth Group, to process some of its patient claims billings. In February 2024, CHC announced that it had experienced a cyberattack and as a result had to temporarily shut down some of its information technology systems. This system shut down caused delays in billing and reimbursement processes to CHC’s customers and, as a result, CHC established a Temporary Funding Assistance Program to help bridge the gap in short-term cash flow needs for customers affected by the disruption of its services due to the cyberattack. Funding distributed through this program is interest free and has no other fees or costs associated with it.  

During the year ended December 31, 2024, the Company received approximately $1.1 million through CHC’s Temporary Assistance Program. On October 28, 2024, the Company received a notice from CHC stating that they have restored the connectivity of their systems and are requesting repayment of the funds the Company received through the Temporary Assistance Program. The repayment date contained in the notice is January 2, 2025.

From January 1, 2025 through the date of issuance of this Quarterly Report on Form 10-Q, we have made approximately $0.2 million in repayments to CHC and written off another $0.1 million, leaving a balance of approximately $0.8 million. The Company will make equal monthly payments of approximately $83,000 from May 2025 to January 2026 to settle this balance.